First Time Loading...

Horizon Therapeutics PLC
NASDAQ:HZNP

Watchlist Manager
Horizon Therapeutics PLC Logo
Horizon Therapeutics PLC
NASDAQ:HZNP
Watchlist
Price: 116.3 USD
Updated: May 6, 2024

Horizon Therapeutics PLC
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Horizon Therapeutics PLC
Cash from Investing Activities Peer Comparison

Comparables:
ALKS
AMRN
PRTA
M
MURA

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Horizon Therapeutics PLC
NASDAQ:HZNP
Cash from Investing Activities
-$142.9m
CAGR 3-Years
29%
CAGR 5-Years
-60%
CAGR 10-Years
-70%
Alkermes Plc
NASDAQ:ALKS
Cash from Investing Activities
$53.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amarin Corporation PLC
NASDAQ:AMRN
Cash from Investing Activities
-$25.5m
CAGR 3-Years
N/A
CAGR 5-Years
-236%
CAGR 10-Years
N/A
Prothena Corporation PLC
NASDAQ:PRTA
Cash from Investing Activities
-$2.8m
CAGR 3-Years
-140%
CAGR 5-Years
-10%
CAGR 10-Years
-19%
M
Mural Oncology PLC
NASDAQ:MURA
Cash from Investing Activities
-$3.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Horizon Therapeutics PLC's Cash from Investing Activities?
Cash from Investing Activities
-142.9m USD

Based on the financial report for Jun 30, 2023, Horizon Therapeutics PLC's Cash from Investing Activities amounts to -142.9m USD.

What is Horizon Therapeutics PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-70%

Over the last year, the Cash from Investing Activities growth was 38%. The average annual Cash from Investing Activities growth rates for Horizon Therapeutics PLC have been 29% over the past three years , -60% over the past five years , and -70% over the past ten years .